Chaofeng Liang

Chaofeng Liang

Auto-generated profile, based on publicly available information

Chaofeng Liang

School of Automation Science and Engineering, South China University of Technology, Guangzhou, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
CLChaofeng Liang
Chaofeng Liang
WSWeitong Sun
Weitong Sun
HHHaiyong He
Haiyong He
BZBaoyu Zhang
Baoyu Zhang
CLCong Ling
Cong Ling
YGYing Guo
Ying Guo
Antitumor effect of a new nano-vector with miRNA-135a on malignant glioma Chaofeng Liang,1,* Weitong Sun,2,* Haiyong He,1,* Baoyu Zhang,1 Cong Ling,1 Bocheng Wang,1 Tengchao Huang,1 Bo Hou,1 Ying Guo1 1Department of Neurosurgery, 3rd Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangdong, China; 2The Pharmaceutical College of Jiamusi University, Jiamusi University, Jiamusi, China *These authors contributed equally to this work Introduction: MiR-135a is found to selectively induce apoptosis in glioma cell but not in normal neurons and glial cells. However, low transfection efficacy limits its application in vivo as other miRNAs. We prepared a new kind of nano-vector based on polyethylene glycol methyl ether (mPEG) and hyper-branched polyethylenimine (hy-PEI) in order to improve the miRNA delivery system into the glioma cells. Methods: The mPEG-g-PEI/miR-135a was constructed and detected by 1H NMR and FTIR analyses. Transmission electron microscope was utilized for its characteristics. Stability and release efficiency was assessed by electrophoresis. Biocompatibility was observed and analyzed through co-culture with astrocytes and malignant glioma cells (C6). Transfection rate was monitored by laser confocal microscopy and flow cytometry. The antitumor effect of mPEG-g-PEI/miR-135a to C6 was confirmed in vivo by MR scanning, pathology and survival curve. RT-PCR was used to assay transfection efficiency of mPEG-g-PEI/miR-135a in vitro and in vivo. And Western blotting was used to assess the expressions of the targeted proteins of miR-135a.Results: In this experiment, we found the optimal N/P ratio of mPEG-g-PEI/miR-135a was about 6 judged by Zeta potential, particle size and encapsulation ability. The stability of mPEG-g-PEI/miR-135a in serum and the release efficiency in acid(pH=5.0) of mPEG-g-PEI/miR-135a were simulated the environment in vivo and in tumor. The mPEG-g-PEI nano-vector was co-cultured with malignant glioma cell C6 and normal astrocytes in vitro and showed good biocompatibility evaluated by CCK8 assay. The cell experiments in vitro indicated that mPEG-g-PEI could significantly improve miR-135a transfection by enhancing uptake effect of both normal glial and glioma cells. Given the C6 implanted in situ model, we discovered that the mPEG-g-PEI/miR-135a could obviously increase the survival period and inhibit the growth of glioma confirmed by MRI and histochemistry. In addition, the transfection efficiency of mPEG-g-PEI was better than that of other transfection agents either in vitro or in vivo confirmed by RT-PCR. Moreover, the expressions of the targeted proteins of miR-135a were consistent with the in vitro results. Conclusion: These results suggest that mPEG-g-PEI is expected to provide a new effective intracellular miRNA delivery system with low toxicity for glioma therapy. Keywords: nano-vector, miRNA-135a, malignant glioma, gene delivery, Micro RNA

6 December 2024 in World Neurosurgery
Verified
Journal Article
Open access
YOYunmou Ou
Yunmou Ou
CLChaofeng Liang
Chaofeng Liang
QCQilong Chen
Qilong Chen
JGJin Gong
Jin Gong
MLManting Li
Manting Li
YGYing Guo
Ying Guo
Chiasmatic cavernous hemangioma (CCH) is a rare disease. Most cases are treated with surgical resection through approaches such as pterional and orbitozygomatic craniotomy. However, with advancements in surgical technique and heightened patient demand for improved postoperative quality of life, there have been reports in recent years exploring more minimally invasive surgical approaches, such as the subfrontal trans-eyebrow keyhole and endoscopic endonasal transsphenoidal approach. In this article, the cases of CCH in the reported literature are reviewed, the indications and techniques of minimally invasive surgery for the removal of CCH through the subfrontal trans-eyebrow keyhole approach are discussed, and the effects of different surgical approaches are analyzed. We reviewed the literature on surgical cases of intracranial cavernous hemangiomas (with chiasma as the center) involving the visual pathway published from 2000 to 2023 in PubMed and other relevant databases; ultimately, 55 cases from 37 articles were retrieved, to which we added an additional case, making the total number of cases examined 56. We analyzed the patient's medical records, including pathological symptoms, relationship with the chiasma location, surgical approach, and prognosis. The analysis of the data of 56 cases indicated that most patients experienced a decrease in visual acuity (64.3%) and visual-field defects (58.9%). Gradual changes in pituitary function were also observed (43.8%). The surgical approach is determined by the location of the lesion. Over the past 5 years, although the pterional (46.4%) approach has remained the most common, the proportion of subfrontal (12.5%) approaches has gradually increased. In the case we report, we found that the lesion in the patient involved the anterior chiasma and the right medial optic nerve. The patient presented with acute visual deterioration, suggesting the possibility of hemorrhage in the hemangioma. We attempted the right-sided subfrontal trans-eyebrow keyhole approach and achieved complete resection of the cavernous hemangioma. Postoperatively, the patient showed improvement in visual acuity and visual field, with obvious recovery observed at the 3-month follow-up. According to our results, the subfrontal trans-eyebrow keyhole approach for the resection of CCH is mainly suitable for cases in which the lesions are located above and anterior to the optic chiasm, the medial or superior aspect of the intracranial segment of the optic nerve is involved, and there is no invasion into the optic nerve canal. Compared with the traditional surgical approach, the minimally invasive subfrontal trans-eyebrow keyhole approach has demonstrated better clinical outcomes in the resection of CCH. However, according to the specific conditions of different patients, it is still necessary to comprehensively consider the choice of surgical approach. This study provides a valuable reference for further exploration of the treatment of CCH.

1 July 2020 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
CLChaofeng Liang
Chaofeng Liang
WSWeitong Sun
Weitong Sun
HHHaiyong He
Haiyong He
BZBaoyu Zhang
Baoyu Zhang
CLCong Ling
Cong Ling
YGYing Guo
Ying Guo
Antitumor Effect of a New Nano-Vector with miRNA-135a on Malignant Glioma [Corrigendum]